Document Detail


Update on device technologies for monitoring heart failure.
MedLine Citation:
PMID:  22911315     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
Congestive heart failure (CHF) affects more than 5 million people in the United States and is one of the most common reasons for recurrent hospitalizations. Since the majority of admissions related to CHF are secondary to progressively worsening congestion, many clinicians are quick to initiate aggressive diuresis once early signs of impending heart failure develop. These signs are based in large measure on patient-reported symptoms. Unfortunately, recent trials have shown that traditional ambulatory monitoring of heart failure using patient symptoms or body weight do not reduce episodes of decompensated heart failure requiring hospitalization. This has led to great interest in developing monitoring systems that can detect impending episodes of CHF even prior to the development of symptoms. Some of the these systems utilize existing implantable cardioverter defibrillators and cardiac resynchronization therapy devices to monitor electrophysiologic parameters including the presence of ventricular arrhythmias, heart rate variability and even transthoracic impedances. Other more recent developments have focused on more invasive hemodynamic monitoring systems that can measure pressures in the right ventricle, pulmonary arteries and the left atrium. The data on the utility of such systems is limited but encouraging. While none of these systems are currently FDA approved, they have been applied in a number of clinical trials. This paper highlights the currently available monitoring systems for heart failure and reviews the evidence supporting its use.
Authors:
Bharat Singh; Stuart D Russell; Alan Cheng
Related Documents :
9232095 - Effects of repeated short versus single long episodes of focal ischemia on somatosensor...
15095565 - Rapidly progressive dementia due to bilateral internal carotid artery occlusion with in...
17319915 - Seizure-promoting effect of blood-brain barrier disruption.
20702115 - Middle cerebral artery infarct following multiple bee stings.
2272055 - Clinical management of patients with nonsustained ventricular tachycardia: what do we r...
15984905 - Therapeutic potential of monteplase in acute myocardial infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current treatment options in cardiovascular medicine     Volume:  14     ISSN:  1534-3189     ISO Abbreviation:  Curr Treat Options Cardiovasc Med     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-05     Completed Date:  2012-10-02     Revised Date:  2013-07-25    
Medline Journal Info:
Nlm Unique ID:  9815942     Medline TA:  Curr Treat Options Cardiovasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  536-49     Citation Subset:  -    
Affiliation:
Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Carnegie 568, Baltimore, MD, 21287, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer ce...
Next Document:  Persicarin is anti-inflammatory mediator against HMGB1-induced inflammatory responses in HUVECs and ...